Evidence/Findings:
Based on record review and interview, the manager failed to ensure medication administered to a resident was documented in the resident's medical record, for four of four residents sampled. The deficient practice posed a risk as the Department was provided false and misleading information.
Findings include:
1. A review of R1's February 2024 medication administration record (MAR) revealed the following medications were documented as administered on February 27, 2024, prior to the administration of the medications:
-Sertraline 100 milligrams (mg) at 8:00 PM, and
-Laxative Plus 100 mg at 8:00 PM.
2. A review of R1's February 2024 MAR revealed the following medications were documented as administered on February 28, 2024 and February 29, 2024, prior to the administration of the medications:
-Sertraline 100 milligrams (mg) at 8:00 AM and 8:00 PM, and
-Laxative Plus 100 mg at 8:00 AM and 8:00 PM.
3. A review of R3's February 2024 MAR revealed the following medication was documented as administered on February 27, 2024, prior to the administration of the medication:
-Metformin 500 mg at 8:00 PM.
4. A review of R3's February 2024 MAR revealed the following medications were documented as administered on February 28, 2024 and February 29, 2024, prior to the administration of the medications:
-Celebrex 100 mg at 8:00 AM and 8:00 PM;
-Metformin 500 mg at 8:00 AM and 8:00 PM;
-Levothyroxine 50 micrograms (mcg) at 7:00 AM; and
-Januvia 100 mg at 8:00 AM.
5. A review of R3's February 2024 MAR revealed the following medications were documented as administered on February 30, 2024. However, February 30, 2024 is not a valid date on the calendar:
-Metformin 500 mg at 8:00 AM and 8:00 PM;
-Levothyroxine 50 mcg at 7:00 AM; and
-Januvia 100 mg at 8:00 AM.
6. A review of R4's February 2024 MAR revealed the following medication was documented as administered on February 27, 2024, prior to the administration of the medication:
-Escitalopram 20 mg at 8:00 PM;
-Tamsulosin 0.4 mg at 8:00 PM;
-Carvedilol 3.125 mg at 8:00 PM;
-Senna 8.6 mg at 8:00 PM.
7. A review of R4's February 2024 MAR revealed the following medications were documented as administered on February 28, 2024 and February 29, 2024, prior to the administration of the medications:
-Aspirin 81 mg at 8:00 AM;
-Escitalopram 20 mg at 8:00 PM;
-Tamsulosin 0.4 mg at 8:00 PM;
-Spironolactone 25 mg at 8:00 AM;
-Carvedilol 3.125 mg at 8:00 AM;
-Furosemide 40 mg at 8:00 AM; and
-Senna 8.6 mg at 8:00 PM.
8. A review of R4's February 2024 MAR revealed the following medications were documented as administered on February 30, 2024. However, February 30, 2024 is not a valid date on the calendar:
-Carvedilol 3.125 mg at 8:00 PM
-Furosemide 40 mg at 8:00 AM; and
-Senna 8.6 mg at 8:00 AM and 8:00 PM.
9. A review of R5's February 2024 MAR revealed the following medication was documented as administered on February 27, 2024, prior to the administration of the medication:
-Trazodone 50 mg at 8:00 PM;
-Senna 8.6 mg at 8:00 PM.
10. A review of R5's February 2024 MAR revealed the following medications were documented as administered on February 28, 2024 and February 29, 2024, prior to the administration of the medications:
-Trazodone 50 mg at 8:00 PM;
-Amlodipine 10 mg at 8:00 AM; and
-Senna 8.6 mg at 8:00 PM.
11. In an interview, E1 acknowledged the aforementioned medication was documented as administered prior to the medications being administered to R1, R3, R4, and R3 and R4 had medication documented as administered on February 30, 2024.
Summary:
No deficiencies were found during the on-site compliance inspection conducted on October 23, 2025.